Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma

Tetsuzo Tagawa, Licun Wu, Masaki Anraku, Zhihong Yun, Katrina Rey-Mcintyre, Marc De Perrot

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

CD1d-restricted natural killer T (iNKT) cells have been shown to provide adjuvant activity against cancer by producing interferon (IFN)-γ. However, the role of invariant NKT (iNKT) cells in the tumor microenvironment has not yet been fully addressed. Our aim is to elucidate the antitumor effect of iNKT cells in the tumor microenvironment by using an intrathoracic murine malignant pleural mesothelioma model that we had previously developed and to provide pleural effusion as a good surrogate of the tumor microenvironment. We found that the number of iNKT cells increased dramatically in the pleural effusion after intrathoracic tumor cell injection at an earlier phase compared with accumulation of CD8 T cells. These iNKT cells showed increased expression of CD25 and increased ratio of cells positive for IFN-γ intracellular staining. iNKT cells sorted from pleural effusion of tumor burden mice produced larger amount of IFN-γ compared with naive mice. Mice pretreated in vivo with anti-CD1d-blocking Ab showed increased amount of pleural effusion and decreased ratio of total and effector-type CD8 T cells as well as decreased intracellular IFN-γ expression of CD8T-cell in the pleural effusion. In vivo administration of α-galactosylceramide (α-GalCer) showed prolonged survival associated with less pleural effusion and increased ratio of IFN-γ-positive iNKT cells and CD8 T cells in the pleural effusion. Therefore, this study suggests that iNKT cells accumulating in the tumor microenvironment play an antitumor effect by producing IFN-γ and enhancing subsequent CD8 T-cell response. Furthermore, in vivo administration of α-GalCer could suppress mesothelioma growth by activating iNKT cells.

Original languageEnglish
Pages (from-to)391-399
Number of pages9
JournalJournal of Immunotherapy
Volume36
Issue number8
DOIs
Publication statusPublished - Oct 1 2013
Externally publishedYes

Fingerprint

Natural Killer T-Cells
Interferons
Pleural Effusion
Tumor Microenvironment
T-Lymphocytes
Galactosylceramides
Malignant Mesothelioma
Mesothelioma
Tumor Burden
Neoplasms
Staining and Labeling
Injections

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pharmacology
  • Cancer Research

Cite this

Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma. / Tagawa, Tetsuzo; Wu, Licun; Anraku, Masaki; Yun, Zhihong; Rey-Mcintyre, Katrina; De Perrot, Marc.

In: Journal of Immunotherapy, Vol. 36, No. 8, 01.10.2013, p. 391-399.

Research output: Contribution to journalArticle

Tagawa, Tetsuzo ; Wu, Licun ; Anraku, Masaki ; Yun, Zhihong ; Rey-Mcintyre, Katrina ; De Perrot, Marc. / Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma. In: Journal of Immunotherapy. 2013 ; Vol. 36, No. 8. pp. 391-399.
@article{69d03bc1386141b282614d6c8348c89b,
title = "Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma",
abstract = "CD1d-restricted natural killer T (iNKT) cells have been shown to provide adjuvant activity against cancer by producing interferon (IFN)-γ. However, the role of invariant NKT (iNKT) cells in the tumor microenvironment has not yet been fully addressed. Our aim is to elucidate the antitumor effect of iNKT cells in the tumor microenvironment by using an intrathoracic murine malignant pleural mesothelioma model that we had previously developed and to provide pleural effusion as a good surrogate of the tumor microenvironment. We found that the number of iNKT cells increased dramatically in the pleural effusion after intrathoracic tumor cell injection at an earlier phase compared with accumulation of CD8 T cells. These iNKT cells showed increased expression of CD25 and increased ratio of cells positive for IFN-γ intracellular staining. iNKT cells sorted from pleural effusion of tumor burden mice produced larger amount of IFN-γ compared with naive mice. Mice pretreated in vivo with anti-CD1d-blocking Ab showed increased amount of pleural effusion and decreased ratio of total and effector-type CD8 T cells as well as decreased intracellular IFN-γ expression of CD8T-cell in the pleural effusion. In vivo administration of α-galactosylceramide (α-GalCer) showed prolonged survival associated with less pleural effusion and increased ratio of IFN-γ-positive iNKT cells and CD8 T cells in the pleural effusion. Therefore, this study suggests that iNKT cells accumulating in the tumor microenvironment play an antitumor effect by producing IFN-γ and enhancing subsequent CD8 T-cell response. Furthermore, in vivo administration of α-GalCer could suppress mesothelioma growth by activating iNKT cells.",
author = "Tetsuzo Tagawa and Licun Wu and Masaki Anraku and Zhihong Yun and Katrina Rey-Mcintyre and {De Perrot}, Marc",
year = "2013",
month = "10",
day = "1",
doi = "10.1097/CJI.0b013e3182a801f2",
language = "English",
volume = "36",
pages = "391--399",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma

AU - Tagawa, Tetsuzo

AU - Wu, Licun

AU - Anraku, Masaki

AU - Yun, Zhihong

AU - Rey-Mcintyre, Katrina

AU - De Perrot, Marc

PY - 2013/10/1

Y1 - 2013/10/1

N2 - CD1d-restricted natural killer T (iNKT) cells have been shown to provide adjuvant activity against cancer by producing interferon (IFN)-γ. However, the role of invariant NKT (iNKT) cells in the tumor microenvironment has not yet been fully addressed. Our aim is to elucidate the antitumor effect of iNKT cells in the tumor microenvironment by using an intrathoracic murine malignant pleural mesothelioma model that we had previously developed and to provide pleural effusion as a good surrogate of the tumor microenvironment. We found that the number of iNKT cells increased dramatically in the pleural effusion after intrathoracic tumor cell injection at an earlier phase compared with accumulation of CD8 T cells. These iNKT cells showed increased expression of CD25 and increased ratio of cells positive for IFN-γ intracellular staining. iNKT cells sorted from pleural effusion of tumor burden mice produced larger amount of IFN-γ compared with naive mice. Mice pretreated in vivo with anti-CD1d-blocking Ab showed increased amount of pleural effusion and decreased ratio of total and effector-type CD8 T cells as well as decreased intracellular IFN-γ expression of CD8T-cell in the pleural effusion. In vivo administration of α-galactosylceramide (α-GalCer) showed prolonged survival associated with less pleural effusion and increased ratio of IFN-γ-positive iNKT cells and CD8 T cells in the pleural effusion. Therefore, this study suggests that iNKT cells accumulating in the tumor microenvironment play an antitumor effect by producing IFN-γ and enhancing subsequent CD8 T-cell response. Furthermore, in vivo administration of α-GalCer could suppress mesothelioma growth by activating iNKT cells.

AB - CD1d-restricted natural killer T (iNKT) cells have been shown to provide adjuvant activity against cancer by producing interferon (IFN)-γ. However, the role of invariant NKT (iNKT) cells in the tumor microenvironment has not yet been fully addressed. Our aim is to elucidate the antitumor effect of iNKT cells in the tumor microenvironment by using an intrathoracic murine malignant pleural mesothelioma model that we had previously developed and to provide pleural effusion as a good surrogate of the tumor microenvironment. We found that the number of iNKT cells increased dramatically in the pleural effusion after intrathoracic tumor cell injection at an earlier phase compared with accumulation of CD8 T cells. These iNKT cells showed increased expression of CD25 and increased ratio of cells positive for IFN-γ intracellular staining. iNKT cells sorted from pleural effusion of tumor burden mice produced larger amount of IFN-γ compared with naive mice. Mice pretreated in vivo with anti-CD1d-blocking Ab showed increased amount of pleural effusion and decreased ratio of total and effector-type CD8 T cells as well as decreased intracellular IFN-γ expression of CD8T-cell in the pleural effusion. In vivo administration of α-galactosylceramide (α-GalCer) showed prolonged survival associated with less pleural effusion and increased ratio of IFN-γ-positive iNKT cells and CD8 T cells in the pleural effusion. Therefore, this study suggests that iNKT cells accumulating in the tumor microenvironment play an antitumor effect by producing IFN-γ and enhancing subsequent CD8 T-cell response. Furthermore, in vivo administration of α-GalCer could suppress mesothelioma growth by activating iNKT cells.

UR - http://www.scopus.com/inward/record.url?scp=84885044893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885044893&partnerID=8YFLogxK

U2 - 10.1097/CJI.0b013e3182a801f2

DO - 10.1097/CJI.0b013e3182a801f2

M3 - Article

C2 - 23994885

AN - SCOPUS:84885044893

VL - 36

SP - 391

EP - 399

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 8

ER -